NDC 64679-0928 - Lisinopril and hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64679-0928
- Manufacturer
- State of Florida DOH Central Pharmacy
- Effective date
- 2010-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lisinopril and hydrochlorothiazide - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | BluePoint Laboratories | 4f44fb73-7f61-4623-ae89-61abd8e945ab | 2025-09-30 | Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil-hydrochlorothiazide | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | Novadoz Pharmaceuticals LLC | c8197eea-e990-4c0e-bc2d-f080bac8de17 | 2025-09-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | dcb39c6b-430d-4b3d-ba6f-5bf1efe116aa | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Marlex Pharmaceuticals, Inc. | df881501-42ae-624a-e053-2995a90ab2a0 | 2025-09-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | bbf7e20d-dfc2-4115-8788-c0cac15a1148 | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5ba2c08b-5ce5-4967-bc3b-2c73df9865af | 2025-09-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Bryant Ranch Prepack | a0b068b4-1e55-446b-912b-3534e9e6fb75 | 2025-09-12 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | ec6dce85-5c0b-475c-af0b-cbbc034f698f | 2025-09-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 60f3f17d-fd28-406d-97ca-9f01f5f1c72c | 2025-09-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NorthStar Rx LLC | 25318baf-9c2f-458f-b9ea-f52dabca49af | 2025-09-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | A-S Medication Solutions | 47054448-7d5f-43c4-8313-70179a7f9a2e | 2025-09-05 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 6b7f96c3-daf4-4029-a96b-baa37add0edb | 2025-09-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 0e015b9a-0ac1-4ec3-bbe7-7a672d30e1f4 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8d56b5db-e72d-4f09-aed4-09e65a27e9ff | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 1898f438-4571-4aab-ae06-9bf1aabf0486 | 2025-09-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | be81ba65-c434-4287-97d3-cd11d6031636 | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | AvKARE | e78b2195-a2da-3d03-e053-2a95a90a7d56 | 2025-08-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Olmesartan medoxomil and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | d421f352-9500-4d3e-8bc3-0cdcc2050514 | 2025-08-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 67bedecc-f758-4bc6-82c5-7d428cbbbd9b | 2025-08-22 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.